P23.5
Congenital pneumonia due to Pseudomonas
Clinical Classification Guidelines
Medical Intelligence & Overview
Congenital pneumonia caused by Pseudomonas is a rare but serious infection that affects newborns. This condition occurs when a newborn acquires the infection from the mother during pregnancy, delivery, or shortly after birth. The infection is caused specifically by Pseudomonas bacteria, which are known for their resistance to many antibiotics and their ability to cause severe respiratory infections. Recognizing and understanding this condition is crucial for prompt treatment and management to ensure the best possible health outcomes for affected infants.
Causes & Symptoms
Clinical Causes: Transmission of Pseudomonas bacteria from mother to baby during childbirth (perinatal transmission). Colonization of the birth canal or environment with Pseudomonas that comes into contact with the newborn during delivery. Postnatal exposure to contaminated hospital environments or equipment carrying Pseudomonas bacteria. Infections in other parts of the mother's body that could potentially spread to the infant via passage through the birth canal. Premature rupture of membranes increasing the risk of bacterial transmission. Use of invasive medical devices or procedures in the neonatal care unit that may introduce bacteria.
Key Symptoms: Respiratory distress, including rapid breathing or difficulty breathing. Coughing and wheezing. Fever or hypothermia (low body temperature). Lethargy or decreased activity levels. Rapid heartbeat (tachycardia). Cyanosis, indicated by a bluish tint to lips or skin due to insufficient oxygen. Poor feeding or refusal to feed. Visual signs of infection such as redness or swelling around the eyes or lips.
Diagnostic & Treatment
Diagnosis Path: Physical examination to assess respiratory and general health status. Chest X-ray to identify lung infiltrates or other abnormalities characteristic of pneumonia. Blood cultures to detect Pseudomonas bacteria in the bloodstream. Samples from respiratory secretions (e.g., tracheal aspirates or bronchoalveolar lavage) for microbiological analysis. Laboratory tests including complete blood count (CBC) to evaluate infection and inflammation markers. Molecular diagnostic assays (such as PCR) may be used for rapid detection of Pseudomonas species.
Treatment Protocols: Administering antibiotics effective against Pseudomonas, such as piperacillin-tazobactam, ceftazidime, or cefepime, tailored based on antibiotic susceptibility testing. Supportive care with oxygen therapy or mechanical ventilation if required to assist breathing. Hydration and nutritional support to maintain overall health and strength. Monitoring for complications, such as sepsis or respiratory failure. Treating any associated infections or underlying conditions to prevent further health issues. In neonatal intensive care units (NICUs), infection prevention protocols are critical to minimize hospital-acquired infections.
Clinical Advice & FAQs
Billing Guidance
Is P23.5 a billable ICD-10 code?
Yes, P23.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P23.5?
Clinical documentation must specify the nature of Congenital pneumonia due to Pseudomonas and any associated comorbidities for accurate reporting.
Cite this Clinical Reference